_version_ 1783344886131458048
author Hisamatsu, Tadakazu
Kunisaki, Reiko
Nakamura, Shiro
Tsujikawa, Tomoyuki
Hirai, Fumihito
Nakase, Hiroshi
Watanabe, Kenji
Yokoyama, Kaoru
Nagahori, Masakazu
Kanai, Takanori
Naganuma, Makoto
Michimae, Hirofumi
Andoh, Akira
Yamada, Akihiro
Yokoyama, Tadashi
Kamata, Noriko
Tanaka, Shinji
Suzuki, Yasuo
Hibi, Toshifumi
Watanabe, Mamoru
author_facet Hisamatsu, Tadakazu
Kunisaki, Reiko
Nakamura, Shiro
Tsujikawa, Tomoyuki
Hirai, Fumihito
Nakase, Hiroshi
Watanabe, Kenji
Yokoyama, Kaoru
Nagahori, Masakazu
Kanai, Takanori
Naganuma, Makoto
Michimae, Hirofumi
Andoh, Akira
Yamada, Akihiro
Yokoyama, Tadashi
Kamata, Noriko
Tanaka, Shinji
Suzuki, Yasuo
Hibi, Toshifumi
Watanabe, Mamoru
author_sort Hisamatsu, Tadakazu
collection PubMed
description
format Online
Article
Text
id pubmed-6077314
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Korean Association for the Study of Intestinal Diseases
record_format MEDLINE/PubMed
spelling pubmed-60773142018-08-08 Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial Hisamatsu, Tadakazu Kunisaki, Reiko Nakamura, Shiro Tsujikawa, Tomoyuki Hirai, Fumihito Nakase, Hiroshi Watanabe, Kenji Yokoyama, Kaoru Nagahori, Masakazu Kanai, Takanori Naganuma, Makoto Michimae, Hirofumi Andoh, Akira Yamada, Akihiro Yokoyama, Tadashi Kamata, Noriko Tanaka, Shinji Suzuki, Yasuo Hibi, Toshifumi Watanabe, Mamoru Intest Res Brief Communication Korean Association for the Study of Intestinal Diseases 2018-07 2018-07-27 /pmc/articles/PMC6077314/ /pubmed/30090050 http://dx.doi.org/10.5217/ir.2018.16.3.494 Text en © Copyright 2018. Korean Association for the Study of Intestinal Diseases. http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Communication
Hisamatsu, Tadakazu
Kunisaki, Reiko
Nakamura, Shiro
Tsujikawa, Tomoyuki
Hirai, Fumihito
Nakase, Hiroshi
Watanabe, Kenji
Yokoyama, Kaoru
Nagahori, Masakazu
Kanai, Takanori
Naganuma, Makoto
Michimae, Hirofumi
Andoh, Akira
Yamada, Akihiro
Yokoyama, Tadashi
Kamata, Noriko
Tanaka, Shinji
Suzuki, Yasuo
Hibi, Toshifumi
Watanabe, Mamoru
Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial
title Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial
title_full Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial
title_fullStr Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial
title_full_unstemmed Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial
title_short Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial
title_sort effect of elemental diet combined with infliximab dose escalation in patients with crohn's disease with loss of response to infliximab: cerisier trial
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077314/
https://www.ncbi.nlm.nih.gov/pubmed/30090050
http://dx.doi.org/10.5217/ir.2018.16.3.494
work_keys_str_mv AT hisamatsutadakazu effectofelementaldietcombinedwithinfliximabdoseescalationinpatientswithcrohnsdiseasewithlossofresponsetoinfliximabcerisiertrial
AT kunisakireiko effectofelementaldietcombinedwithinfliximabdoseescalationinpatientswithcrohnsdiseasewithlossofresponsetoinfliximabcerisiertrial
AT nakamurashiro effectofelementaldietcombinedwithinfliximabdoseescalationinpatientswithcrohnsdiseasewithlossofresponsetoinfliximabcerisiertrial
AT tsujikawatomoyuki effectofelementaldietcombinedwithinfliximabdoseescalationinpatientswithcrohnsdiseasewithlossofresponsetoinfliximabcerisiertrial
AT hiraifumihito effectofelementaldietcombinedwithinfliximabdoseescalationinpatientswithcrohnsdiseasewithlossofresponsetoinfliximabcerisiertrial
AT nakasehiroshi effectofelementaldietcombinedwithinfliximabdoseescalationinpatientswithcrohnsdiseasewithlossofresponsetoinfliximabcerisiertrial
AT watanabekenji effectofelementaldietcombinedwithinfliximabdoseescalationinpatientswithcrohnsdiseasewithlossofresponsetoinfliximabcerisiertrial
AT yokoyamakaoru effectofelementaldietcombinedwithinfliximabdoseescalationinpatientswithcrohnsdiseasewithlossofresponsetoinfliximabcerisiertrial
AT nagahorimasakazu effectofelementaldietcombinedwithinfliximabdoseescalationinpatientswithcrohnsdiseasewithlossofresponsetoinfliximabcerisiertrial
AT kanaitakanori effectofelementaldietcombinedwithinfliximabdoseescalationinpatientswithcrohnsdiseasewithlossofresponsetoinfliximabcerisiertrial
AT naganumamakoto effectofelementaldietcombinedwithinfliximabdoseescalationinpatientswithcrohnsdiseasewithlossofresponsetoinfliximabcerisiertrial
AT michimaehirofumi effectofelementaldietcombinedwithinfliximabdoseescalationinpatientswithcrohnsdiseasewithlossofresponsetoinfliximabcerisiertrial
AT andohakira effectofelementaldietcombinedwithinfliximabdoseescalationinpatientswithcrohnsdiseasewithlossofresponsetoinfliximabcerisiertrial
AT yamadaakihiro effectofelementaldietcombinedwithinfliximabdoseescalationinpatientswithcrohnsdiseasewithlossofresponsetoinfliximabcerisiertrial
AT yokoyamatadashi effectofelementaldietcombinedwithinfliximabdoseescalationinpatientswithcrohnsdiseasewithlossofresponsetoinfliximabcerisiertrial
AT kamatanoriko effectofelementaldietcombinedwithinfliximabdoseescalationinpatientswithcrohnsdiseasewithlossofresponsetoinfliximabcerisiertrial
AT tanakashinji effectofelementaldietcombinedwithinfliximabdoseescalationinpatientswithcrohnsdiseasewithlossofresponsetoinfliximabcerisiertrial
AT suzukiyasuo effectofelementaldietcombinedwithinfliximabdoseescalationinpatientswithcrohnsdiseasewithlossofresponsetoinfliximabcerisiertrial
AT hibitoshifumi effectofelementaldietcombinedwithinfliximabdoseescalationinpatientswithcrohnsdiseasewithlossofresponsetoinfliximabcerisiertrial
AT watanabemamoru effectofelementaldietcombinedwithinfliximabdoseescalationinpatientswithcrohnsdiseasewithlossofresponsetoinfliximabcerisiertrial
AT effectofelementaldietcombinedwithinfliximabdoseescalationinpatientswithcrohnsdiseasewithlossofresponsetoinfliximabcerisiertrial